wet AMD


Also found in: Wikipedia.
Related to wet AMD: Lucentis

wet AMD

n
a form of age-related macular degeneration in which blood vessels grow abnormally under the macula lutea
References in periodicals archive ?
RGX-314 is a novel, one-time subretinal gene therapy being developed for wet AMD and DR.
Regenxbio (RGNX) and Clearside Biomedical (CLSD) announced an option and license agreement for exclusive worldwide rights to Clearside's proprietary, in-office SCS Microinjector for the delivery of RGX-314 to the suprachoroidal space to treat wet age-related macular degeneration, or wet AMD, diabetic retinopathy, or DR, and other conditions for which anti-vascular endothelial growth factor, or anti-VEGF, treatment is currently the standard of care.
ENPNewswire-August 21, 2019--Outlook Therapeutics Completes Patient Enrollment for NORSE 1 a Phase 3 Clinical Trial for ONS-5010 in Wet AMD
M2 EQUITYBITES-April 18, 2019-Innovent Biologics Inc doses first wet AMD patient in Phase I trial of IBI302
Global Banking News-April 18, 2019-Innovent Biologics Inc doses first wet AMD patient in Phase I trial of IBI302
M2 PHARMA-April 18, 2019-Innovent Biologics Inc doses first wet AMD patient in Phase I trial of IBI302
However, these do occur in wet AMD, which is characterized by the excessive growth of blood vessels that can leak blood and fluid.
The policy stated that Avastin would be offered to patients with wet AMD 'as the preferred treatment option' because of the price difference between Avastin and the other two medicines.
A judge in London rejected an action brought by Bayer and Novartis against 12 NHS clinical commissioning groups (CCGs) in the North East, who had decided to use a drug called Avastin to treat certain patients with wet agerelated macular degeneration (wet AMD).
Wet AMD is generally caused by abnormal blood vessels that leak fluid or blood into the region of the macula in the center of the retina and almost always begins as dry AMD.